$3.720
+0.051 (+1.36%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BCYC Prediction & Forecast by Similar Chart Analysis
Alphio's BCYC stock price prediction model matches the current Bicycle Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.75 (+0.94%). The 1-week path is $3.75 (+0.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC (BCYC) is currently trading at $3.62, which is significantly below the Oppenheimer price target of $11, suggesting a potential upside of approximately 174%. However, the stock has shown a year-to-date decline of 45.81% and a 52-week range that indicates it is near its low of $3.33. While the gross margin remains strong at 96.8%, the company reported a substantial net loss of $10.48 million in Q3 2026, which is concerning. The RSI of 43.08 indicates the stock is nearing oversold territory, but the overall trend remains bearish. Given these factors, it may be prudent to hold rather than buy at this time, as the risks of further declines are present, especially with a recent earnings miss and declining revenues.
BCYC stock price ended at $3.72 on Wednesday, after rising +1.36%
Bicycle Therapeutics PLC (BCYC) last closed at $3.72, gaining +1.36%. These facts feed the 1-day and 1-week BCYC price prediction above.
Forecast Drivers
Bicycle Therapeutics PLC (BCYC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BCYC, ranked by similarity.
Seasonality analysis for BCYC
Historically the probability of a positive November return for BCYC is 46.51%. November offers the highest probability of a positive month at 46.51%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BCYC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $5.22 | $6.03 | $7.53 | +62.19% |
| Dec 2026 | $6.21 | $7.15 | $7.67 | +92.15% |
In 2026, Bicycle Therapeutics PLC (BCYC) is projected to range from $5.22 to $7.67.
Bicycle Therapeutics PLC 2026 monthly forecast
In Nov 2026, Bicycle Therapeutics PLC is projected to average $6.03, with a low of $5.22 and high of $7.53.
In Dec 2026, Bicycle Therapeutics PLC is projected to average $7.15, with a low of $6.21 and high of $7.67.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.